Trials / Completed
CompletedNCT02169804
An Open-Label Study to Evaluate the Effect of Age Upon the Pharmacokinetics of Androxal
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Repros Therapeutics Inc. · Industry
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
• To determine and compare the pharmacokinetics (PK) of 3 doses of 25 mg Androxal in elderly healthy adult male subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Androxal 25 mg |
Timeline
- Start date
- 2014-08-01
- Primary completion
- 2014-08-01
- Completion
- 2014-08-01
- First posted
- 2014-06-23
- Last updated
- 2014-10-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02169804. Inclusion in this directory is not an endorsement.